Skip to main content

CORRECTION article

Front. Psychiatry, 09 May 2023
Sec. Psychopharmacology
Volume 14 - 2023 | https://doi.org/10.3389/fpsyt.2023.1198103
This article is part of the Research Topic Down the rabbit hole – the psychological and neural mechanisms of psychedelic compounds and their use in treating mental health and medical conditions View all 14 articles

Corrigendum: Psychedelic replications in virtual reality and their potential as a therapeutic instrument: an open-label feasibility study

This article is a correction to:

  1. Psychedelic replications in virtual reality and their potential as a therapeutic instrument: an open-label feasibility study

    1. Read original article
\r\nKarl Kristjan Kaup Karl Kristjan Kaup1*Madis VasserMadis Vasser1Kadi TulverKadi Tulver1Mari MunkMari Munk2Juhan Pikame,Juhan Pikamäe1,3Jaan Aru Jaan Aru1*
  • 1Institute of Computer Science, University of Tartu, Tartu, Estonia
  • 2Psychiatry Clinic of North Estonia Medical Centre, Tallinn, Estonia
  • 3Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia

A corrigendum on
Psychedelic replications in virtual reality and their potential as a therapeutic instrument: an open-label feasibility study

by Kaup, K. K., Vasser, M., Tulver, K., Munk, M., Pikamäe, J., and Aru, J. (2023). Front. Psychiatry 14:1088896. doi: 10.3389/fpsyt.2023.1088896

In the published article, there was an error in the author list, and author Mari Munk was erroneously excluded. The corrected author list appears below.

Karl Kristjan Kaup1*, Madis Vasser1, Kadi Tulver1, Mari Munk2, Juhan Pikamäe1, 3 and Jaan Aru1*

1Institute of Computer Science, University of Tartu, Tartu, Estonia

2Psychiatry Clinic of North Estonia Medical Centre, Tallinn, Estonia

3Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: psychedelics, virtual reality, therapy, therapeutic mechanisms of psychedelics, altered states of consciousness (ASC), VR-augmented therapy, depression, depressive disorder

Citation: Kaup KK, Vasser M, Tulver K, Munk M, Pikamäe J and Aru J (2023) Corrigendum: Psychedelic replications in virtual reality and their potential as a therapeutic instrument: an open-label feasibility study. Front. Psychiatry 14:1198103. doi: 10.3389/fpsyt.2023.1198103

Received: 31 March 2023; Accepted: 21 April 2023;
Published: 09 May 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Kaup, Vasser, Tulver, Munk, Pikamäe and Aru. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Karl Kristjan Kaup, kaup.kristjan@gmail.com; Jaan Aru, jaan.aru@gmail.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.